Clover Health Investments (CLOV) Projected to Post Quarterly Earnings on Thursday

Clover Health Investments (NASDAQ:CLOV) is expected to be releasing its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $467.0560 million for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, February 26, 2026 at 5:00 PM ET.

Clover Health Investments Trading Up 2.0%

Shares of CLOV opened at $2.01 on Wednesday. Clover Health Investments has a 12 month low of $1.94 and a 12 month high of $4.52. The firm’s 50 day moving average is $2.36 and its 200-day moving average is $2.64. The stock has a market capitalization of $1.04 billion, a PE ratio of -18.27 and a beta of 2.09.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on CLOV shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Clover Health Investments in a report on Monday, December 29th. Wall Street Zen upgraded Clover Health Investments from a “sell” rating to a “hold” rating in a research report on Sunday, February 15th. Zacks Research downgraded Clover Health Investments from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 24th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $3.70 price objective on shares of Clover Health Investments in a research report on Tuesday, January 20th. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $3.23.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Virtu Financial LLC lifted its holdings in shares of Clover Health Investments by 532.9% in the fourth quarter. Virtu Financial LLC now owns 209,204 shares of the company’s stock worth $492,000 after acquiring an additional 176,150 shares during the last quarter. Tudor Investment Corp ET AL acquired a new position in Clover Health Investments during the 4th quarter worth approximately $458,000. Quadrature Capital Ltd bought a new position in Clover Health Investments in the 4th quarter valued at approximately $29,000. Schonfeld Strategic Advisors LLC bought a new position in Clover Health Investments in the 4th quarter valued at approximately $29,000. Finally, Abel Hall LLC acquired a new stake in Clover Health Investments in the fourth quarter valued at approximately $27,000. Institutional investors and hedge funds own 19.77% of the company’s stock.

Clover Health Investments Company Profile

Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.

At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.